Insmed Incorporated (INSM)
NASDAQ: INSM · IEX Real-Time Price · USD
25.10
+0.17 (0.68%)
May 16, 2024, 4:00 PM EDT - Market closed

Insmed Revenue

Insmed had revenue of $315.49M in the twelve months ending March 31, 2024, with 22.54% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $75.50M with 15.77% year-over-year growth. In the year 2023, Insmed had annual revenue of $305.21M with 24.39% growth.

Revenue (ttm)
$315.49M
Revenue Growth
+22.54%
P/S Ratio
11.79
Revenue / Employee
$345,936
Employees
912
Market Cap
3.72B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023305.21M59.85M24.39%
Dec 31, 2022245.36M56.90M30.19%
Dec 31, 2021188.46M24.05M14.63%
Dec 31, 2020164.41M27.95M20.48%
Dec 31, 2019136.47M126.63M1,287.56%
Dec 31, 20189.84M--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 201311.50M--
Dec 31, 20120--
Dec 31, 20114.42M-2.50M-36.18%
Dec 31, 20106.92M-3.45M-33.28%
Dec 31, 200910.37M-1.33M-11.33%
Dec 31, 200811.70M4.12M54.32%
Dec 31, 20077.58M6.56M639.61%
Dec 31, 20061.03M894.00K682.44%
Dec 31, 2005131.00K-6.00K-4.38%
Dec 31, 2004137.00K-13.00K-8.67%
Dec 31, 2003150.00K-1.81M-92.33%
Dec 31, 20021.96M1.66M560.47%
Dec 31, 2001296.00K236.00K393.33%
Dec 31, 200060.00K--
Dec 31, 19990--
Dec 31, 19980--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Perrigo Company 4.56B
Alkermes 1.73B
RadNet 1.66B
Integer Holdings 1.63B
HUTCHMED (China) 838.00M
Ultragenyx Pharmaceutical 442.59M
Axsome Therapeutics 251.02M
PROCEPT BioRobotics 156.33M
Revenue Rankings